BIO-B vs RGEN

Comparison between Bio-Rad Laboratories Inc - Class B (BIO-B, Company) and Repligen Corp (RGEN, Company).

Both BIO-B and RGEN are from the Healthcare sector.

5-Year PerformanceRGEN has outperformed BIO-B, delivering a return of -5.6% compared to -14.5%

BIO-B vs RGEN - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	BIO-B(COMPANY)	RGEN(COMPANY)
Market Cap	$8.34B	$8.35B
Max Drawdown	72.48%	92.06%
Sharpe Ratio	0.59	0.58
5Y Beta	-0.10	1.33
Industry	Medical Devices	Medical Instruments & Supplies
P/E Ratio	-16.92	162.20
Forward P/E	34.97	73.53
PEG Ratio	N/A	0.62
5Y EPS CAGR	N/A	9.09%
Debt to Equity	11.72%	25.96%
Free Cash Flow Yield	4.28%	1.27%

Market Cap

BIO-B

$8.34B

Winner

RGEN

$8.35B

Max Drawdown

Winner

BIO-B

72.48%

RGEN

92.06%

Sharpe Ratio

Winner

BIO-B

0.59

RGEN

0.58

5Y Beta

Winner

BIO-B

-0.10

RGEN

1.33

Industry

BIO-B

Medical Devices

RGEN

Medical Instruments & Supplies

P/E Ratio

Winner

BIO-B

-16.92

RGEN

162.20

Forward P/E

Winner

BIO-B

34.97

RGEN

73.53

PEG Ratio

BIO-B

N/A

RGEN

0.62

5Y EPS CAGR

BIO-B

N/A

RGEN

9.09%

Debt to Equity

Winner

BIO-B

11.72%

RGEN

25.96%

Free Cash Flow Yield

Winner

BIO-B

4.28%

RGEN

1.27%

BIO-B vs RGEN - Historical Returns

Returns include dividend reinvestment.

Period	BIO-B	RGEN
1 month	+1.72%	+13.14%
3 months	+11.69%	+12.23%
6 months	-0.43%	-8.43%
1 year	+20.03%	+25.37%
5 years(CAGR)	-14.46%	-5.56%
10 years(CAGR)	+8.10%	+18.53%
Max(CAGR)	+13.08%	+15.46%

BIO-B

+1.72%

Winner

RGEN

+13.14%

BIO-B

+11.69%

Winner

RGEN

+12.23%

Winner

BIO-B

-0.43%

RGEN

-8.43%

BIO-B

+20.03%

Winner

RGEN

+25.37%

5Y(CAGR)

BIO-B

-14.46%

Winner

RGEN

-5.56%

10Y(CAGR)

BIO-B

+8.10%

Winner

RGEN

+18.53%

Max(CAGR)

BIO-B

+13.08%

Winner

RGEN

+15.46%

BIO-B vs RGEN - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

Year	BIO-B	RGEN
2026	-0.43%	-9.91%
2025	-4.58%	+14.55%
2024	+1.54%	-19.72%
2023	-20.76%	+10.99%
2022	-44.94%	-34.37%
2021	+25.91%	+38.91%
2020	+54.89%	+104.34%
2019	+60.70%	+78.95%
2018	-3.46%	+42.31%
2017	+30.08%	+16.47%
2016	+33.03%	+9.68%
2015	+14.67%	+40.75%
2014	-2.37%	+56.77%
2013	+15.80%	+105.73%
2012	+6.31%	+79.43%
2011	-9.98%	-23.23%
2010	+6.86%	+16.09%
2009	+31.80%	+4.85%
2008	-30.83%	-43.16%
2007	+28.86%	+133.93%
2006	+28.31%	-27.95%
2005	+14.04%	+37.93%
2004	-2.64%	-30.77%
2003	+36.47%	+47.14%
2002	+32.81%	+13.01%
2001	+103.17%	-31.63%
2000	+36.25%	+10.19%
1999	-0.56%	-1.98%

BIO-B vs RGEN Drawdown Comparison

The maximum drawdown for BIO-B was -72.48%, occurring on Apr 9, 2025. This drawdown has not yet recovered.

The maximum drawdown for RGEN was -92.06%, occurring on Jul 23, 2004. Recovery took 3565 trading sessions.

The current BIO-B drawdown is -62.21%. The current RGEN drawdown is -54.33%.

Rank	BIO-B	RGEN
#1	-72.48% Sep 10, 2021 - Apr 9, 2025	-92.06% Mar 3, 2000 - May 7, 2014
#2	-50.14% Aug 11, 2008 - Apr 20, 2010	-68.27% Sep 23, 2021 - May 15, 2026
#3	-35.34% Mar 1, 2000 - Nov 29, 2000	-50.33% Jul 7, 2015 - Jun 23, 2017
#4	-34.33% Jun 19, 2002 - May 20, 2003	-39.47% Nov 18, 1999 - Jan 24, 2000
#5	-31.86% Sep 4, 2018 - Aug 2, 2019	-32.87% Sep 18, 2017 - Jun 22, 2018
#6	-31.00% May 3, 2011 - Jan 9, 2014	-29.94% Nov 8, 2018 - Apr 26, 2019
#7	-27.68% Nov 8, 2007 - Aug 11, 2008	-26.69% Feb 12, 2021 - Jul 27, 2021
#8	-25.78% May 3, 2010 - Mar 7, 2011	-26.06% Feb 18, 2000 - Mar 1, 2000
#9	-23.33% Dec 26, 2003 - Aug 2, 2005	-24.16% Jul 14, 2014 - Oct 28, 2014
#10	-22.65% Feb 1, 2007 - Sep 27, 2007	-23.73% Oct 30, 2014 - Jan 16, 2015
#11	-20.71% May 17, 2002 - Jun 17, 2002	-22.69% Aug 1, 2019 - Jan 9, 2020
#12	-19.75% Feb 18, 2020 - Apr 14, 2020	-22.16% Feb 19, 2020 - Apr 22, 2020
#13	-19.59% Jun 6, 2003 - Dec 26, 2003	-19.46% May 15, 2020 - Jul 30, 2020
#14	-18.74% Feb 20, 2014 - Mar 12, 2015	-17.65% Feb 10, 2000 - Feb 15, 2000
#15	-18.70% Nov 6, 2020 - Feb 12, 2021	-15.69% Jan 19, 2021 - Feb 11, 2021